HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.

@article{Tabrizi2014HPVGP,
  title={HPV genotype prevalence in Australian women undergoing routine cervical screening by cytology status prior to implementation of an HPV vaccination program.},
  author={Sepehr N. Tabrizi and Julia M.L. Brotherton and Matthew P. Stevens and John Rhys Condon and Peter B. McIntyre and David W. Smith and Suzanne Marie Garland},
  journal={Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology},
  year={2014},
  volume={60 3},
  pages={
          250-6
        }
}
  • S. Tabrizi, J. Brotherton, +4 authors S. Garland
  • Published 1 July 2014
  • Medicine
  • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
BACKGROUND Data on the prevalence of cervical HPV genotypes in Australia by age and by grade of cytological abnormality are sparse. OBJECTIVE Measure prevalence of HPV genotypes among 2620 Australian women by age and cytology status. STUDY DESIGN Women presenting for routine Pap smear screening were recruited from diverse regions, including a significant sample of Indigenous women. DNA extracts prepared from Thinprep specimens were HPV genotyped by Roche LINEAR ARRAY HPV. RESULTS HPV… 
Genotyping and follow-up of HR-HPV types detected by self-sampling in women from low socioeconomic groups not participating in regular cervical cancer screening in France.
  • C. Tamalet, P. Halfon, +5 authors L. Piana
  • Medicine
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
  • 2016
TLDR
This study illustrates the potential efficacy of self-sampling as a cancer screening strategy for socioeconomically deprived women who do not participate in regular Pap screening programs.
Quadrivalent human papillomavirus vaccination successfully reduces the prevalence of vaccine-targeted genotypes in a young, vaccine-eligible-age sample of Australian females.
TLDR
In a community sample of vaccine-eligible-age females with a high vaccine uptake, the prevalence of vaccine -related HPV genotypes is extremely low and early sexual debut and multiple sexual partners are positively associated with HPV, underscoring the importance of vaccination at the routinely recommended age of 12-13 years for best vaccine impact.
Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introduction.
TLDR
Vaccination has changed the epidemiology of HPV infection in Australian women, having markedly reduced the prevalence of vaccine-targeted types, including amongst women with known risk factors for infection.
Human papillomavirus prevalence to age 60 years among Australian women prevaccination.
TLDR
The shape of the prevalence curve the authors observed is similar to those from other Western populations, likely due to differences in sexual behaviour between populations and over time, reactivation of HPV during perimenopause, and possibly the presence of cervical screening programs.
Baseline prevalence and type distribution of Human papillomavirus in sexually active non-vaccinated adolescent girls from Argentina.
TLDR
Results confirm that HPV (particularly HR-types) are very common among sexually active adolescents, and prevalence rises quickly after their sexual debut, and may be used to monitor post-vaccinal longitudinal changes in Argentina.
The prevalence and genotype distribution of human papillomaviruses among women in Taizhou, China
TLDR
The prevalence and genotype distribution of HPV varied with age and cervical lesions, and the highest prevalence of HPV infection was found in women aged ≥60 years (40.72%).
Distribution of Carcinogenic Human Papillomavirus Genotypes and Association to Cervical Lesions among Women in Fez (Morocco)
TLDR
The distribution of carcinogenic HPV types in the studied population is different from the data in other regions but epidemiological studies in other Moroccan regions are required.
The Prevalence of Human Papilloma Virus (HPV) in Women using Liquid Base Pap Smear in Rasht, Northern of Iran.
TLDR
A moderate prevalence of HPV infection is evidenced in high-risk women in Rasht by wet Pap smear from 2010 to 2015 but needs to be given more attention because in apparently healthy women also, HPV infection was observed.
Cervical pathology in high-risk human papillomavirus- positive, cytologically normal women.
TLDR
The prevalence of significant cervical pathology among women who are high-risk human papillomavirus (HR-HPV)-positive/cytology negative, the most common combination of positive co-tests, was 2.4%.
Community-Based Prevalence of Genital Human Papilloma Virus (HPV) Infection: a Systematic Review and Meta-Analysis
TLDR
The prevalence rates in this systematic quantitative review provide a reliable estimate of the burden of HPV infection among asymptomatic women from developed as well as developing nations.
...
1
2
3
...

References

SHOWING 1-10 OF 49 REFERENCES
HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia
TLDR
These findings provide the largest dataset of HPV genotype prevalence rates within Australian women, though they are not representative of the general population.
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.
TLDR
The HPV types most commonly detected are similar to those most commonly described in pre-neoplastic and cancer cases, although the relative contribution of HPV16 and HPV18 is substantially lower in cytologically normal women.
Prevalence and genotype identification of human papillomavirus in women undergoing voluntary cervical cancer screening in Molise, central Italy.
TLDR
The results of the present investigation provide further evidence for the notion that cervical HPV infection is more widespread than previously suggested.
Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program
TLDR
Differences were found in the prevalence of risk factors and some other HPV genotypes among Australian women, reinforcing the importance of cervical screening as a complement to vaccination for all women and the value of baseline data on HPV genotype prevalence by Indigenous status and residence.
Prevalence and genotyping of HPV in cervical cancer among Australian women
TLDR
HPV infection is present in the vast majority of cervical cancer patients, however, its presence or genotyping does not seem to have a major influence on the pathogenesis of cervical cancers, such as tumor grade, FIGO staging and metastasis.
Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia
TLDR
The results indicate that the two most prevalent CC-associated HPV genotypes in Australia parallel those described internationally, with type variations thereafter.
Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia
Multicenter international phase III clinical trials using multivalent human papillomavirus (HPV) vaccines for cervical cancer (CC) prevention are underway. As HPV immunity is type specific, defining
Prevalence of different HPV types and estimation of prognostic risk factors based on the linear array HPV genotyping test
The aim of the study was to evaluate the prevalence and risk factors of HPV in a gynecologic population attending outpatient clinics using two new molecular tests. The Amplicor HPV test and the
Age-specific prevalence of infection with human papillomavirus in females: a global review.
PURPOSE Global data on age-specific prevalence of human papillomavirus (HPV) infection overall, and for high-risk HPV types 16 and 18, are essential for the future implementation of HPV prophylactic
Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance.
TLDR
In screened populations, younger women with CIN3 are more likely to have HPV16 detected, and surveillance specimens for HPV typing should be both age stratified and lesion specific.
...
1
2
3
4
5
...